Evidence map›Paper›PMID 26417002›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Psychosocial Outcomes in Adult Survivors of Retinoblastoma.

Jennifer S Ford, Joanne F Chou, Charles A Sklar, Kevin C Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Leslie L Robison, Ruth A Kleinerman, Yuelin Li, Brian P Marr and 2 more

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. NCCN Guidelines Insights: Survivorship, Version 1.2016.Journal of the National Comprehensive Cancer Network : JNCCN · 2016
    Guideline
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Jennifer S FordJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD. fordj@mskcc.org.
Joanne F ChouJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Charles A SklarJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Kevin C OeffingerJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Danielle Novetsky FriedmanJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Mary McCabeJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Leslie L RobisonJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Ruth A KleinermanJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Yuelin LiJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Brian P MarrJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
David H AbramsonJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Ira J DunkelJennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Bristol-Myers Squibb (Germany) · DEGlaxoSmithKline (Brazil) · BRKettering University · USNational Cancer Institute · USCornell University · USSt. Jude Children's Research Hospital · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Mach-LETSGO: Machine-LEarning of Treatment, Survey, and Genetics towards Obtaining Correct Classification of Chronic Conditions in Adult Survivors in the Childhood Cancer Survivor Study - CCSS SupplU24CA055727 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Gregory Armstrong · 1999 to 2026
$96.7M
Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Clinical and Translational Science CenterKL2TR000458 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$2.1M
Survivorship: Mentoring and Bridging Primary Care and OncologyK05CA160724 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI OEFFINGER, KEVIN CHARLES · 2011 to 2015
$821k
NCATS NIH HHS KL2 TR000458NCATS NIH HHS KL2TR000458NCATS NIH HHS UL1 TR000457NCI NIH HHS K05 CA160724NCI NIH HHS K05CA160724NCI NIH HHS P30 CA008748NCI NIH HHS P30CA008748NCI NIH HHS U24 CA055727NCI NIH HHS U24CA55727
6 · The paper itself

Abstract

purposeSurvival rates for individuals diagnosed with retinoblastoma (RB) exceed 95% in the United States; however, little is known about the long-term psychosocial outcomes of these survivors. PATIENTS AND

methodsAdult RB survivors, diagnosed from 1932 to 1994 and treated in New York, completed a comprehensive questionnaire adapted from the Childhood Cancer Survivor Study (CCSS), by mail or telephone. Psychosocial outcomes included psychological distress, anxiety, depression, somatization, fear of cancer recurrence, satisfaction with facial appearance, post-traumatic growth, and post-traumatic stress symptoms; noncancer CCSS siblings served as a comparison group.

resultsA total of 470 RB survivors (53.6% with bilateral RB; 52.1% female) and 2,820 CCSS siblings were 43.3 (standard deviation [SD], 11) years and 33.2 (SD, 8.4) years old at the time of study, respectively. After adjusting for sociodemographic factors, RB survivors did not have significantly higher rates of depression, somatization, distress, or anxiety compared with CCSS siblings. Although RB survivors were more likely to report post-traumatic stress symptoms of avoidance and/or hyperarousal (both P < .01), only five (1.1%) of 470 met criteria for post-traumatic stress disorder. Among survivors, having a chronic medical condition did not increase the likelihood of psychological problems. Bilateral RB survivors were more likely than unilateral RB survivors to experience fears of cancer recurrence (P < .01) and worry about their children being diagnosed with RB (P < .01). However, bilateral RB survivors were no more likely to report depression, anxiety, or somatic complaints than unilateral survivors.

conclusionMost RB survivors do not have poorer psychosocial functioning compared with a noncancer sample. In addition, bilateral and unilateral RB survivors seem similar with respect to their psychological symptoms.

Indexed as

AdolescentAdultAgedEyeEye EnucleationFearFemaleFollow-Up StudiesHealth StatusHumansMaleMiddle AgedNeoplasm Recurrence, LocalPsychologyRetinoblastomaRetrospective Studies

Identifiers

PMID26417002
PMCPMC4622100
OpenAlexW2222927661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.